Transcripts MaxCyte, Inc.

Equities

MXCT

US57777K1060

Delayed London S.E. Other stock markets 04:39:28 2024-04-29 am EDT			5-day change	1st Jan Change
290 ^GBX	-1.69%		-7.94%	-17.73%

Apr. 02	MaxCyte inks deal with Be Bio; Orcadian firms farmout	AN
Apr. 02	MaxCyte, Inc. Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : MaxCyte, Inc., 2023 Earnings Call, Mar 12, 2024	Mar. 12
Transcript : MaxCyte, Inc., Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
Transcript : MaxCyte, Inc., Q3 2023 Sales/ Trading Statement Call, Oct 04, 2023	23-10-04
Transcript : MaxCyte, Inc., Q2 2023 Earnings Call, Aug 09, 2023	23-08-09
Transcript : MaxCyte, Inc., Q1 2023 Earnings Call, May 10, 2023	23-05-10
Transcript : MaxCyte, Inc., Q4 2022 Earnings Call, Mar 15, 2023	23-03-15
Transcript : MaxCyte, Inc., Q3 2022 Earnings Call, Nov 09, 2022	22-11-09
Transcript : MaxCyte, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 04:40 PM	22-09-13
Transcript : MaxCyte, Inc., Q2 2022 Earnings Call, Aug 10, 2022	22-08-10
MaxCyte, Inc. Provides Revenue Guidance for the Year 2022	22-08-10	CI
Transcript : MaxCyte, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 04:40 PM	22-05-11
Transcript : MaxCyte, Inc., Q1 2022 Earnings Call, May 09, 2022	22-05-09
MaxCyte, Inc. Provides Revenue Guidance for the Full Year 2022	22-05-09	CI
Maxcyte, Inc. Provides Revenue Guidance for the First Quarter of 2022	22-04-12	CI
MaxCyte, Inc. Provides Revenue Guidance for the Year 2022	22-03-23	CI
Transcript : MaxCyte, Inc., Q4 2021 Earnings Call, Mar 22, 2022	22-03-22
Transcript : MaxCyte, Inc. - Shareholder/Analyst Call	22-02-07
Maxcyte, Inc. Provides Preliminary Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2021	22-01-24	CI
Transcript : MaxCyte, Inc., Q3 2021 Earnings Call, Nov 10, 2021	21-11-10
Transcript : MaxCyte, Inc., Q2 2021 Earnings Call, Sep 13, 2021	21-09-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts MaxCyte, Inc.

Equities

MXCT

US57777K1060

Transcripts

Filters